LOS ANGELES, Feb. 13, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Arconic Corporation (“Arconic” or “the Company”) (ARNC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of…
Tag: PR Newswire
LOS ANGELES, Feb. 13, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Elastic N.V. (“Elastic” or “the Company”) (NYSE: ESTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of…
GUANGZHOU, China, Feb. 13, 2025 /PRNewswire/ — As China’s No.1 platform for international trade, the 137th Canton Fair has successfully hosted a Southeast Asia roadshow with trade promotion events in Vietnam, Laos and Cambodia in January. “The 137th Canton Fair will further optimize…
LOS ANGELES, Feb. 13, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc (“GSK” or “the Company”) (NYSE: GSK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and…
BEIJING, Feb. 13, 2025 /PRNewswire/ — Gaotu Techedu Inc. (“Gaotu” or the “Company”) (NYSE: GOTU), a technology-driven education company and online large-class tutoring service provider in China, today announced that it will report its financial results for the fourth quarter and fiscal…
XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM). After the mainland of China, South Korea, Australia and Singapore, Taiwan market is the fifth APAC market in which XPOVIO® has been approved for…
LOS ANGELES, Feb. 13, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Intellia Therapeutics, Inc. (“Intellia” or “the Company”) (NASDAQ: NTLA) for violations of §§10(b) and 20(a) of the Securities…
LOS ANGELES, Feb. 13, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Neumora Therapeutics, Inc. (“Neumora” or “the Company”) (NASDAQ: NMRA) for violations of the federal securities laws….
SHANGHAI, 13 février 2025 /PRNewswire/ — Un reportage de french.shanghai.gov.cn Le dernier plan d’action pour l’amélioration de l’environnement des affaires, publié à Shanghai le 5 février, aidera la ville à mieux répondre aux besoins des entités du marché et à injecter plus de vitalité…
LOS ANGELES, Feb. 13, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cerevel Therapeutics Holdings, Inc. (“Cerevel” or “the Company”) (NASDAQ: CERE) for violations of the…